Remimazolam and Ciprofol: More Research Is Needed but Ask the Right Questions and Perhaps Aim Higher
Year: 2024
Type: article
Abstract: City dwellers of a certain age will recall lengthy waits for a bus followed eventually by the arrival of three on the same route driving nose-to-tail. So it is with intravenous hypnotics. Since the discovery of propofol, it has been a long wait. Now we have remimazolam (two different versions) launched worldwide, ciprofol in phase 3 studies, and several other candidates in the early stages of development.
Source: Anesthesiology
Authors: J. Robert Sneyd, Brian J. Anderson
Institutions: University of Plymouth, University of Auckland
Language: English
Subfield: Anesthesiology and Pain Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4404255721